Athena Countouriotis - Net Worth and Insider Trading
Athena Countouriotis Net Worth
The estimated net worth of Athena Countouriotis is at least $8 Million dollars as of 2024-10-10. Athena Countouriotis is the President & CEO of Turning Point Therapeutics Inc and owns about 110,330 shares of Turning Point Therapeutics Inc (TPTX) stock worth over $8 Million. Athena Countouriotis is also the Director of Passage Bio Inc and owns about 18,900 shares of Passage Bio Inc (PASG) stock worth over $12,094. Details can be seen in Athena Countouriotis's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Athena Countouriotis has not made any transactions after 2022-02-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Athena Countouriotis
Athena Countouriotis Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Athena Countouriotis owns 6 companies in total, including Iovance Biotherapeutics Inc (IOVA) , Turning Point Therapeutics Inc (TPTX) , and Passage Bio Inc (PASG) among others .
Click here to see the complete history of Athena Countouriotis’s form 4 insider trades.
Insider Ownership Summary of Athena Countouriotis
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
IOVA | Iovance Biotherapeutics Inc | 2020-06-08 | director |
TPTX | Turning Point Therapeutics Inc | 2022-02-09 | director & President & CEO |
PASG | Passage Bio Inc | 2020-03-24 | director |
2018-01-23 | director | ||
2017-06-19 | SVP & Chief Medical Officer | ||
2015-01-05 | SVP and Chief Medical Officer |
Athena Countouriotis Latest Holdings Summary
Athena Countouriotis currently owns a total of 2 stocks. Among these stocks, Athena Countouriotis owns 110,330 shares of Turning Point Therapeutics Inc (TPTX) as of February 9, 2022, with a value of $8 Million and a weighting of 99.86%. Athena Countouriotis also owns 18,900 shares of Passage Bio Inc (PASG) as of March 24, 2020, with a value of $12,094 and a weighting of 0.14%.
Latest Holdings of Athena Countouriotis
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TPTX | Turning Point Therapeutics Inc | 2022-02-09 | 110,330 | 76.01 | 8,386,183 |
PASG | Passage Bio Inc | 2020-03-24 | 18,900 | 0.64 | 12,094 |
Holding Weightings of Athena Countouriotis
Athena Countouriotis Form 4 Trading Tracker
According to the SEC Form 4 filings, Athena Countouriotis has made a total of 3 transactions in Turning Point Therapeutics Inc (TPTX) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Turning Point Therapeutics Inc is the sale of 2,971 shares on February 9, 2022, which brought Athena Countouriotis around $107,847.
According to the SEC Form 4 filings, Athena Countouriotis has made a total of 2 transactions in Passage Bio Inc (PASG) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Passage Bio Inc is the acquisition of 10,000 shares on March 24, 2020, which cost Athena Countouriotis around $149,800.
Insider Trading History of Athena Countouriotis
- 1
Athena Countouriotis Trading Performance
GuruFocus tracks the stock performance after each of Athena Countouriotis's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Athena Countouriotis is 50.44%. GuruFocus also compares Athena Countouriotis's trading performance to market benchmark return within the same time period. The performance of stocks bought by Athena Countouriotis within 3 months outperforms 5 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Athena Countouriotis's insider trading performs compared to the benchmark.
Performance of Athena Countouriotis
Athena Countouriotis Ownership Network
Athena Countouriotis Owned Company Details
What does Iovance Biotherapeutics Inc do?
Who are the key executives at Iovance Biotherapeutics Inc?
Athena Countouriotis is the director of Iovance Biotherapeutics Inc. Other key executives at Iovance Biotherapeutics Inc include General Counsel Frederick G Vogt , Chief Operating Officer Igor Bilinsky , and Chief Financial Officer Jean-marc Bellemin .
Iovance Biotherapeutics Inc (IOVA) Insider Trades Summary
Over the past 18 months, Athena Countouriotis made no insider transaction in Iovance Biotherapeutics Inc (IOVA). Other recent insider transactions involving Iovance Biotherapeutics Inc (IOVA) include a net purchase of 10,000,000 shares made by Wayne P. Rothbaum , and a net purchase of 260,000 shares made by Merrill A Mcpeak .
In summary, during the past 3 months, insiders sold 0 shares of Iovance Biotherapeutics Inc (IOVA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Iovance Biotherapeutics Inc (IOVA) were sold and 10,260,000 shares were bought by its insiders, resulting in a net purchase of 10,260,000 shares.
Iovance Biotherapeutics Inc (IOVA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Iovance Biotherapeutics Inc Insider Transactions
Athena Countouriotis Mailing Address
Above is the net worth, insider trading, and ownership report for Athena Countouriotis. You might contact Athena Countouriotis via mailing address: C/o Ambit Biosciences Corporation, 11080 Roselle Street, San Diego Ca 92121.